Oxum Glycosciences Start a conversation

Next-generation cancer diagnostics

Cancer changes glycans.
We detect the difference.

Sequencing the last major class of biomarkers to detect cancer across multiple glycoproteins.

Explore our approach Partner with us
Oxum scientists developing glycan sequencing technology in the lab
01

GlycoSeq™
Decoding the glycome.

From a familiar blood sample to a more specific molecular readout.

01 The problem

Biology has another
information layer.

Glycans carry disease information that today's diagnostic tools struggle to detect.

The 4thmajor biomarker layer, alongside DNA, RNA, and proteins

Glycan patterns reveal cell state—not just protein abundance.

Experimentally determined human glycosylated IgG1 Fc structure with its resolved N-glycan, PDB 5JII

Human glycosylated IgG1 Fc · X-ray structure · PDB 5JII ↗

02 Our approach

The missing layer,
made readable.

GlycoSeq™ reads glycan patterns across multiple proteins to build richer, multi-marker cancer signatures.

01CaptureIsolate the target protein
02SequenceRead its glycan pattern
03InterpretResolve the clinical signal
03 Platform vision

Building belief,
one biomarker at a time.

Profile disease-linked glycan patterns across protein panels and cancer types.

Broad disease scope

Many cancers

Detect patterns across cancer types.

01 — CANCERS
Multi-marker context

Many glycoproteins

Read panels, not isolated markers.

02 — PANELS
Enabling technology

GlycoSeq™

Turn glycans into diagnostic data.

03 — PLATFORM
04 Partners

Science moves
together.

PartnerHyde Park Labs
BackerInsi
05 The team

Built by scientists.
Driven by urgency.

Chemical biology, molecular engineering, and disciplined execution.

Arthur Costa, CEO at Oxum GlycosciencesCEO

Arthur Costa

BS Chemical Biology, UChicago ’27

Research experience with Jack Szostak and Jennifer Doudna. 2026 Goldwater Scholar.

Nora Levy, COO at Oxum GlycosciencesCOO

Nora Levy

BA/MA Economics, UChicago ’27

Operations, fundraising, and long-term project management.

Michael Bolgov, CTO at Oxum GlycosciencesCTO

Michael Bolgov

BS Molecular Engineering, UChicago ’27

Biomolecular engineering research and quantitative product strategy.

06 Join Oxum

Help build a more
specific future.

Join a focused team building a new diagnostic platform.

View opportunities
01

Staff Scientist

Lead experiments and translate our roadmap into lab practice.

Now hiring
02

Lab Technician

Run experiments alongside senior scientists.

Now hiring
03

Oxum Interns

Hands-on research for early undergraduates.

Now hiring
07 Contact

Let's move diagnostics
forward.

Research, investment, careers, or collaboration.

contact@oxumglyco.com